Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 4;16(5):1045.
doi: 10.3390/cancers16051045.

Monoclonal Antibodies for Targeted Fluorescence-Guided Surgery: A Review of Applicability across Multiple Solid Tumors

Affiliations
Review

Monoclonal Antibodies for Targeted Fluorescence-Guided Surgery: A Review of Applicability across Multiple Solid Tumors

Stefano Giuliani et al. Cancers (Basel). .

Abstract

This study aims to review the status of the clinical use of monoclonal antibodies (mAbs) that have completed or are in ongoing clinical trials for targeted fluorescence-guided surgery (T-FGS) for the intraoperative identification of the tumor margins of extra-hematological solid tumors. For each of them, the targeted antigen, the mAb generic/commercial name and format, and clinical indications are presented, together with utility, doses, and the timing of administration. Based on the current scientific evidence in humans, the top three mAbs that could be prepared in a GMP-compliant bank ready to be delivered for surgical purposes are proposed to speed up the translation to the operating room and produce a few readily available "off-the-shelf" injectable fluorescent probes for safer and more effective solid tumor resection.

Keywords: fluorophores; monoclonal antibodies; solid malignancies; surgical oncology; targeted fluorescence-guided surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Conjugation of anti-GD2 monoclonal antibodies (mAbs) with IRDye800CW and in vitro and in vivo binding experiments on neuroblastoma cells expressing the GD2 antigen.

Similar articles

Cited by

References

    1. Zahavi D., Weiner L. Monoclonal Antibodies in Cancer Therapy. Antibodies. 2020;9:34. doi: 10.3390/antib9030034. - DOI - PMC - PubMed
    1. Larson S.M., Carrasquillo J.A., Cheung N.-K.V., Press O.W. Radioimmunotherapy of human tumours. Nat. Rev. Cancer. 2015;15:347–360. doi: 10.1038/nrc3925. - DOI - PMC - PubMed
    1. Nagaya T., Nakamura Y.A., Choyke P.L., Kobayashi H. Fluorescence-Guided Surgery. Front. Oncol. 2017;7:314. doi: 10.3389/fonc.2017.00314. - DOI - PMC - PubMed
    1. Nguyen Q.T., Tsien R.Y. Fluorescence-guided surgery with live molecular navigation—A new cutting edge. Nat. Rev. Cancer. 2013;13:653–662. doi: 10.1038/nrc3566. - DOI - PMC - PubMed
    1. Paraboschi I., De Coppi P., Stoyanov D., Anderson J., Giuliani S. Fluorescence imaging in pediatric surgery: State-of-the-art and future perspectives. J. Pediatr. Surg. 2021;56:655–662. doi: 10.1016/j.jpedsurg.2020.08.004. - DOI - PubMed